Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug ...

One of the greatest revolutions in the field of pain medication was the isolation of morphine from the opium poppy in the ...

The acute pain market is rapidly evolving, driven by the increasing demand for non-opioid pain management solutions amidst growing concerns over the opioid crisis. These alternatives aim to offer ...

MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

OpEd: Insurance companies are blocking the best treatments that help patients ease pain without opioids. This must change.

After years of investment to upgrade its manufacturing capabilities, Pacira BioSciences figures it’s time to retire a facility that has been running for more than a decade. | After years spent ...

Sharon Wrona, DNP, discusses novel guidelines from the American Academy of Pediatrics on outpatient opioid prescribing in ...

A new study in the journal Pharmacy says that patients with chronic pain who used marijuana for at least one year “exhibited ...

AstraZeneca may have washed its hands of AZD4041 after the opioid use disorder (OUD) prospect demonstrated a potential drug-drug interaction last year, but the pharma’s development partner, Eolas T | ...

Suzetrigine is the first new non-opioid painkiller in over 20 years. Unlike opioids, which act in the brain, this drug blocks pain close to where it is happening, meaning it has little possibility ...

Shares of Artelo Biosciences, Inc. (ARTL) more than doubled on Monday after the company announced favorable results from its ...

In what seems *** significant step forward in pain management, the US Food and Drug Administration has approved *** new non-opioid painkiller for treating short term pain in adults.